Is Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Superior Even to Lenvatinib? A Matching-Adjusted Indirect Comparison
Andrea Casadei‐Gardini, Toshifumi Tada, Shigeo Shimose, Takashi Kumada, Takashi Niizeki, Stefano Cascinu, Alessandro Cucchetti
Topics & Concepts
AtezolizumabMedicineLenvatinibBevacizumabHepatocellular carcinomaOncologyInternal medicineCarcinomaCancerChemotherapyPembrolizumabImmunotherapySorafenibHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesColorectal Cancer Treatments and Studies